DexCom, Inc. (DXCM) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dexcom, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.256 All participants are in a listen-only mode. 00:00:03.256 -- 00:00:06.420 Later, we will conduct a question and answer session. 00:00:06.420 -- 00:00:11.527 During the question and answer session, if you have a question, please press star 00:00:11.527 -- 00:00:15.092 followed by the number one on your touchtone phone. 00:00:15.092 -- 00:00:18.297 As a reminder, the conference is being recorded. 00:00:18.297 -- 00:00:23.444 I will now turn the call over to Shawn Christensen, Vice President of Finance and 00:00:23.444 -- 00:00:27.648 Investor Relations. Shawn, you may begin. 00:00:27.993 -- 00:00:31.618 Welcome to Dexcom's first quarter 2025 earnings call. 00:00:31.618 -- 00:00:36.245 Our agenda begins with Kevin Sayre, Dexcom's chairman, president, and CEO, who will summarize 00:00:36.245 -- 00:00:40.531 our recent highlights and ongoing strategic initiatives, followed by a financial review 00:00:40.531 -- 00:00:43.775 and outlook from Jeremy Sylvain, our chief financial officer. 00:00:43.775 -- 00:00:46.920 Following our prepared remarks, we will open the call up for your questions. 00:00:46.920 -- 00:00:50.565 At that time, we ask analysts to limit themselves to one question each so we can provide 00:00:50.565 -- 00:00:53.086 an opportunity for everyone participating today. 00:00:53.086 -- 00:00:57.390 Please note that there are also slides available related to our first quarter 2025 performance 00:00:57.390 -- 00:01:02.274 on the Dexcom Investor Relations website on the events and presentations page. 00:01:02.274 -- 00:01:04.977 With that, let's review our safe harbor statement. 00:01:04.977 -- 00:01:09.160 Some of the statements we will make on today's call may constitute forward-looking statements. 00:01:09.160 -- 00:01:13.705 T...